Projects per year
Fingerprint
Dive into the research topics where Nick Devoogdt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
AIIFUND165: Advancing toward a first-in-human beta cell imaging trial using a single domain antibody targeting DPP6
Devoogdt, N. (Administrative Promotor)
1/04/26 → 31/03/29
Project: Fundamental
-
EUAR249: Drivin Car: Developing robust in vivo nanomedicine-based chimeric antigen receptor technology
Devoogdt, N. (Administrative Promotor)
1/03/26 → 28/02/30
Project: Applied
-
IOFPOC72: IOF PoC Project - BiPET-8-69: Bispecific anti-hCD8b/hCD69 PET tracer for in vivo imaging of activated CD8+ T cells
Van Ginderachter, J. (Administrative Promotor), Devoogdt, N. (CoI (Co-Promotor)), De Groof, T. (CoI (Co-Promotor)) & Raes, G. (CoI (Co-Promotor))
1/01/26 → 31/12/26
Project: Applied
-
FWOTM1292: VIROSCAN: Viral G Protein-Coupled Receptor Signaling in Oncogenesis and Immune evasion
De Groof, T. (Mandate) & Devoogdt, N. (Administrative Promotor)
1/11/25 → 31/10/28
Project: Fundamental
-
FWOSB205: SIROCCO: optimization of nanobody Screening dIRected tOwards nanoCar-t Cell develOpment
Blommaert, E.M.-T. M. (Mandate), Devoogdt, N. (Administrative Promotor), Breckpot, K. (CoI (Co-Promotor)) & De Groof, T. (CoI (Co-Promotor))
1/11/25 → 31/10/29
Project: Fundamental
-
A comparative in vitro analysis of pannexin1-targeting agents
Peeters, D., Iaculli, D., Ballet, S., Devoogdt, N., De Groof, T., Vinken, M. & Van Campenhout, R., 1 Mar 2026, In: Biochemical Pharmacology. 245, 11 p., 117688.Research output: Contribution to journal › Article › peer-review
-
A comparative in vitro analysis of pannexin1-targeting agents
Peeters, D., Iaculli, D., Ballet, S., Devoogdt, N., De Groof, T., Vinken, M. & Van Campenhout, R., 26 Jul 2026.Research output: Unpublished contribution to conference › Poster
-
ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
Hernot, S. (Inventor), Devoogdt, N. (Inventor), Mateusiak, L. (Inventor) & De Groof, T. (Inventor), 2026, USPTO, Patent No. US20260139066A1Research output: Patent
-
Asparaginyl peptide ligase-mediated radiolabelling of single-domain antibodies
Bridoux, J. (Inventor), Devoogdt, N. (Inventor), Lescar, J. (Inventor), EL SAHILI, A. (Inventor) & LIU , C. F. (Inventor), 2026, Patent No. EP4673554A1Research output: Patent
-
AXL-Specific Single-Domain Antibodies: A Novel Diagnostic and Therapeutic Strategy in PDAC
Denis, A., Michiels, E., Baldan, J., Satilmis, H., Zhan, D., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K., Breckpot, K., Devoogdt, N., Rooman, I. & De Veirman, K., 6 Feb 2026. 1 p.Research output: Unpublished contribution to conference › Poster
Datasets
-
Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery
Mateusiak, L. (Creator), Floru, S. (Researcher), De Groof, T. (Researcher), Wouters, J. (Researcher), Declerck, N. (Researcher), Debie, P. (Researcher), Janssen, S. (Researcher), Zeven, K. (Researcher), Puttemans, J. (Researcher), Vincke, C. (Researcher), Breckpot, K. (Project Member), Devoogdt, N. (Project Member) & Hernot, S. (Supervisor), Zenodo, 26 Mar 2025
DOI: https://zenodo.org/records/15089920
Dataset
-
DataSet-Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model
Ertveldt, T. (Creator), De Beck, L. (Creator), De Ridder, K. (Creator), Locy, H. (Creator), de Mey, W. (Creator), Goyvaerts, C. (Creator), Lecocq, Q. (Creator), Ceuppens, H. (Creator), De Vlaeminck, Y. (Creator), Awad, R. M. (Creator), Keyaerts, M. (Creator), Devoogdt, N. (Creator), D'Huyvetter, M. (Creator), Breckpot, K. (Creator) & Krasniqi, A. (Creator), Zenodo, 16 Dec 2024
Dataset
-
Dataset Imaging of Tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer
Lauwers, Y. (Creator), Van Ginderachter, J. (Creator), Devoogdt, N. (Creator), De Groof, T. (Creator), Vincke, C. (Creator), Van Craenenbroeck, J. (Creator), Raes, G. (Creator), De Pauw, T. (Creator), Mora Barthelmess, R. (Creator), Jumapili, A. N. (Creator), Courtoy, G. (Creator) & Waelput, W. (Creator), Zenodo, 5 Dec 2024
Dataset
-
Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury
Van Campenhout, R. (Creator), De Groof, T. (Creator), Kadam, P. (Researcher), Muyldermans, S. (Supervisor), Devoogdt, N. (Supervisor) & Vinken, M. (Supervisor), Journal of Nanobiotechnology, 2023
DOI: 10.1186/s12951-023-02137-1
Dataset
-
dataset of Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β
De Groof, T. (Creator), Lauwers, Y. (Creator), De Pauw, T. (Creator), Saxena, M. (Creator), Vincke, C. (Creator), Van Craenenbroeck, J. (Creator), Chapon, C. (Creator), Grand, R. L. (Creator), Raes, G. (Creator), Van Ginderachter, J. (Creator) & Devoogdt, N. (Creator), Zenodo, 19 Mar 2025
Dataset
Prizes
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Krasniqi, A. (Recipient), D'Huyvetter, M. (Recipient), Devoogdt, N. (Recipient) & Keyaerts, M. (Recipient), 16 Apr 2019
Prize: Prize (including medals and awards)
-
Best Poster Presentation
Vandewalle, N. (Recipient), Menu, E. (Recipient), De Bruyne, E. (Recipient), De Veirman, K. (Recipient), Breckpot, K. (Recipient) & Devoogdt, N. (Recipient), 2 Feb 2024
Prize: Prize (including medals and awards)
-
Certificat of Young Speaker Award
Lecocq, Q. (Recipient), Broos, K. (Recipient), Bridoux, J. (Recipient), Raes, G. (Recipient), Xavier, C. (Recipient), Devoogdt, N. (Recipient), Keyaerts, M. (Recipient) & Breckpot, K. (Recipient), 1 Feb 2019
Prize: Prize (including medals and awards)
File -
Development of a nanoCAR-T cell approach for the treatment of multiple myeloma
Hanssens, H. (Recipient), Devoogdt, N. (Recipient), De Veirman, K. (Recipient) & Breckpot, K. (Recipient), 15 Dec 2021
Prize: Fellowship awarded competitively
-
Development of a nanoCAR-T-cell approach for the treatment of multiple myeloma
Hanssens, H. (Recipient), Devoogdt, N. (Recipient) & Breckpot, K. (Recipient), 2024
Prize: Prize (including medals and awards)
Activities
-
Translational imaging of immunity with nanobody probes
Devoogdt, N. (Speaker)
1 Jul 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
K215725N FWO Travel grant for a short research stay at NTU Singapore
Bridoux, J. (Recipient) & Devoogdt, N. (Supervisor)
12 Apr 2025 → 26 Apr 2025Activity: Other
-
Imaging tumor immunity with nanobody tracers
Devoogdt, N. (Speaker)
4 Jun 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Nanobodies making a difference in diagnostics and therapeutics
Devoogdt, N. (Speaker)
19 May 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
AXL-specific Single-Domain Antibodies Modulate the Immune Microenvironment and Enhance Checkpoint Blockade in AML
Zhan, D. (Presenter), Vandewalle, N. (Contributor), Satilmis, H. (Contributor), Verheye, E. (Contributor), De Bruyne, E. (Contributor), Menu, E. (Contributor), Vanderkerken, K. (Contributor), Breckpot, K. (Contributor), Devoogdt, N. (Contributor) & De Veirman, K. (Contributor)
25 Sept 2025Activity: Talk or presentation › Talk or presentation at a conference
Press/Media
-
VUB team develops breakthrough nanobody technology against liver inflammation
Van Campenhout, R., Vinken, M., Devoogdt, N. & De Groof, T.
8/12/23
1 item of Media coverage
Press/Media: Other
-
Betaalbare kankerimmunotherapie
Breckpot, K., Devoogdt, N., De Vlaeminck, Y. & Meeus, F.
8/02/22
1 item of Media coverage
Press/Media: Research
-
VUB-onderzoekers en start-up Esobiotec willen kankerimmunotherapie betaalbaarder maken
Breckpot, K., Devoogdt, N., Meeus, F. & De Vlaeminck, Y.
31/01/22
1 item of Media coverage
Press/Media: Research
-
VUB-onderzoekers en start-up Esobiotec streven naar betaalbare kankerimmunotherapie
Breckpot, K., Devoogdt, N., De Vlaeminck, Y. & Meeus, F.
31/01/22
1 Media contribution
Press/Media: Research
-
EsoBiotec ready to transform cell therapy cancer treatments
30/09/21
1 item of Media coverage
Press/Media: Research
Thesis
-
Assessment of antigen-binding domain parameters important for adequate CAR-T-cell activation: evaluating different SLAMF7-targeting nanobodies.
Meeus, F. ((PhD) Student), Hanssens, H. ((PhD) Student), De Veirman, K. (Co-promotor) & Devoogdt, N. (Promotor), Hanssens, H. (Advisor), 19 Jun 2020Student thesis: Master's Thesis
-
Bead based immunoassay of HER2 ECD domain using nanobodies
Adaga, E. ((PhD) Student), Muyldermans, S. (Promotor), De Pauw, P. (Co-promotor) & Devoogdt, N. (Jury), 1 Sept 2015Student thesis: Master's Thesis
-
CD20 Nb TRNT: targeted radionuclide therapy of non-hodgkin-lymphoma with anti-CD20 nanobodies
Devoogdt, N. (Promotor), D'Huyvetter, M. (Promotor) & Tavernier, J. (Co-promotor), 24 May 2019Student thesis: Doctoral Thesis
-
Characterization of anti-B7-H3 single domain antibody fragments for imaging and targeted radionuclide therapy of cancer
Munir, A. ((PhD) Student), D'Huyvetter, M. (Promotor) & Devoogdt, N. (Co-promotor), Funeh, C. N. (Advisor), 4 Sept 2023Student thesis: Master's Thesis
-
Characterization of CD163-specific nanobodies as immunotracers to non-invasively visualize immunosuppressive macrophages in cancer models
Emami, M. ((PhD) Student), Devoogdt, N. (Promotor) & Van Ginderachter, J. (Co-promotor), Lauwers, Y. (Advisor), 3 Feb 2023Student thesis: Master's Thesis